PTPRC and neoplasm: Two key properties of the tumor-promoting CD45+CD11b+Gr-1+ cell population is that they emerge from the bone marrow, and therefore are a systemic response and not tissue-specific, and that they possess immune-suppressor properties (specifically T-cell suppression) [12, 18].